The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2015

Filed:

Apr. 04, 2014
Applicant:

The Translational Genomics Research Institute, Phoenix, AZ (US);

Inventors:

Kimberly J. Bussey, Phoenix, AZ (US);

Michael J. Demeure, Phoenix, AZ (US);

Aditi Bapat, Phoenix, AZ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); A61K 31/519 (2006.01); A61K 31/496 (2006.01); A61K 45/06 (2006.01); A61K 31/366 (2006.01); A61K 31/4184 (2006.01); A61K 31/428 (2006.01); A61K 31/437 (2006.01); A61K 31/47 (2006.01); A61K 31/69 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/366 (2013.01); A61K 31/4184 (2013.01); A61K 31/428 (2013.01); A61K 31/437 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/69 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention is directed to methods for treating cancer in a subject, such as a cancer of the endocrine system. In some aspects, the method includes administering to the subject one or more of a polo-like kinase 1 inhibitor, a mouse double minute 2 inhibitor, and/or a mitotic catastrophe inducing compound. In other aspects, the method includes measuring an expression level of one or more markers, including caspase 8 and caspase 9, to assess the functionality of the caspase cascade in the subject.


Find Patent Forward Citations

Loading…